Switch to:
More From Other Websites
Sarepta Therapeutics to Announce Third Quarter 2016 Financial Results and Recent Corporate... Oct 24 2016
Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry Oct 21 2016
Trader Be Nimble, Trader Be Quick Oct 20 2016
Sarepta Muscular Dystrophy Drug Interrupts 5-Day Biotech Slump Oct 18 2016
Sarepta Therapeutics: If You Approve It They Will Come Oct 18 2016
PTC Therapeutics Falls on FDA Denial of DMD Drug Appeal Oct 18 2016
Coverage initiated on Sarepta Therapeutics by Credit Suisse Oct 18 2016
Pardon Me, but I Have a Few Things to Say... Seattle Genetics, Biomarin, Sarepta, TG Therapeutics Oct 13 2016
Today’s Trending Stocks: Sarepta, Humana, HTG Molecular Diagnostics, and More Oct 12 2016
Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO Oct 12 2016
Health insurers split on coverage of Sarepta’s Duchenne drug Oct 11 2016
Sarepta Tumbles After Anthem’s Refusal (SRPT, ANTM) Oct 10 2016
New Anthem policy will cost DMD patients $300,000 or more Oct 08 2016
Anthem says will not cover Sarepta's approved Duchenne drug Oct 07 2016
Why Sarepta Therapeutics, Ralph Lauren, Fifth Third Bancorp, and Two Other Stocks Are in Spotlight... Oct 07 2016
Anthem won't cover first FDA-approved Duchenne drug Oct 07 2016
Sarepta Therapeutics (SRPT) Stock Drops, Anthem Says DMD Drug 'Not Medically Necessary' Oct 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)